Cantor Fitzgerald Reiterates Neutral on Aspira Womens Health, Maintains $3.3 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn reiterated a Neutral rating on Aspira Womens Health (NASDAQ:AWH) and maintained a $3.3 price target.
April 10, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald analyst Ross Osborn reiterated a Neutral rating on Aspira Womens Health and maintained a $3.3 price target.
The reiteration of a Neutral rating and maintenance of the price target by a reputable analyst suggests no significant short-term price movement is expected. The analysis is based on the analyst's current assessment of the company's value and market position.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100